The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

15 Sep 2017 16:48

RNS Number : 9435Q
Maven Income & Growth VCT 4 PLC
15 September 2017
 

Maven Income and Growth VCT 4 PLC

 

Issue of Equity - Dividend Investment Scheme

 

 

The Board of Maven Income and Growth VCT 4 PLC (the Company) confirms that, on 15 September 2017 and under its Dividend Investment Scheme (DIS), the Company issued and allotted 40,423 new ordinary shares of 10p each (Ordinary Shares) at a price of 89.29p per share which, under the Terms and Conditions of the DIS, is equivalent to the latest announced net asset value per share.

 

As a result, and in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, the Company confirms that its issued share capital as at 15 September 2017 comprises 32,704,925 Ordinary Shares, with each share carrying one voting right. The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required, under the Disclosure Guidance and Transparency Rules, to notify their interest, or a change to their interest, in the Company.

 

Application has been made to the UK Listing Authority and the London Stock Exchange for the new Ordinary Shares issued under the DIS to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that admission will become effective and dealings will commence on, or around, 21 September 2017.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

15 September 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEGGUMCBUPMGAA
Date   Source Headline
9th Nov 20173:58 pmRNSNet Asset Value(s)
8th Nov 201710:10 amRNSResult of General Meeting
25th Oct 20173:00 pmRNSDividend Declaration
18th Oct 201710:43 amRNSReplacement Statement re Listing Application
17th Oct 20172:49 pmRNSStatement re Listing Application
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:48 pmRNSIssue of Equity
15th Sep 201710:08 amRNSStatement re NAV and Dividend Investment Scheme
8th Sep 20177:00 amRNSHalf-year Report
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
29th Aug 20174:11 pmRNSNet Asset Value(s)
10th Aug 20174:38 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
15th Jun 20174:00 pmRNSDividend Declaration
12th Jun 20174:24 pmRNSTransaction in Own Shares
17th May 20172:33 pmRNSNet Asset Value and Final Dividend
17th May 20172:25 pmRNSResult of AGM
7th Apr 20173:45 pmRNSAnnual Financial Report
2nd Mar 20173:11 pmRNSTransaction in Own Shares
28th Feb 20172:40 pmRNSNet Asset Value and Final Dividend
20th Dec 20164:51 pmRNSTransaction in Own Shares
10th Nov 201611:05 amRNSNet Asset Value(s)
23rd Sep 20165:10 pmRNSTransaction in Own Shares
20th Sep 20164:56 pmRNSTransaction in Own Shares
26th Aug 20164:07 pmRNSHalf-year Report
17th Aug 20162:12 pmRNSNet Asset Value(s)
24th May 20163:06 pmRNSTransaction in Own Shares
27th Apr 20161:50 pmRNSNet Asset Value(s) - Replacement
27th Apr 201612:58 pmRNSResult of AGM
27th Apr 201612:55 pmRNSNet Asset Value(s)
30th Mar 20165:29 pmRNSAnnual Financial Report
22nd Mar 20162:44 pmRNSTransaction in Own Shares
10th Mar 20164:55 pmRNSTransaction in Own Shares
8th Mar 20164:37 pmRNSTransaction in Own Shares
7th Mar 20164:33 pmRNSTransaction in Own Shares
2nd Mar 20164:09 pmRNSNet Asset Value and Proposed Final Dividend
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
27th Nov 20154:36 pmRNSTransaction in Own Shares
17th Nov 201512:59 pmRNSTransaction in Own Shares
16th Nov 20152:17 pmRNSTransaction in Own Shares
12th Nov 201510:34 amRNSNet Asset Value(s)
4th Sep 20153:20 pmRNSTransaction in Own Shares
28th Aug 201512:20 pmRNSHalf Yearly Report
24th Aug 20153:39 pmRNSStatement re Dividend Investment Scheme
20th Aug 20154:50 pmRNSTransaction in Own Shares
20th Aug 201511:47 amRNSStatement re Net Asset Value and Dividend
23rd Jun 20154:51 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.